FACTANKER · measured, cited, anchored official records connected

BioLife Solutions, Inc. — Revenue by Fiscal Year

16 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/0c509a19-af76-423d-b855-f71dd8aefe09/serie/revenue

Fiscal yearRevenuePeriodEvidence
FY 2025$96.2M2025-01-01 – 2025-12-31evidence 0001628280-26-012294
FY 2024$74.6M2024-01-01 – 2024-12-31evidence 0001628280-26-012294
FY 2023$68.0M2023-01-01 – 2023-12-31evidence 0001628280-26-012294
FY 2022$76.2M2022-01-01 – 2022-12-31evidence 0001628280-25-009511
FY 2021$119.2M2021-01-01 – 2021-12-31evidence 0001437749-22-007869
FY 2020$48.1M2020-01-01 – 2020-12-31evidence 0001437749-21-007867
FY 2019$27.4M2019-01-01 – 2019-12-31evidence 0001437749-20-011046
FY 2018$19.7M2018-01-01 – 2018-12-31evidence 0001437749-19-004980
FY 2017$11.0M2017-01-01 – 2017-12-31evidence 0001437749-19-004980
FY 2016$8.2M2016-01-01 – 2016-12-31evidence 0001144204-17-014799
FY 2015$6.4M2015-01-01 – 2015-12-31evidence 0001354488-16-006364
FY 2014$6.2M2014-01-01 – 2014-12-31evidence 0001354488-16-006364
FY 2013$8.9M2013-01-01 – 2013-12-31evidence 0001354488-14-000653
FY 2012$5.7M2012-01-01 – 2012-12-31evidence 0001354488-13-001572
FY 2011$2.8M2011-01-01 – 2011-12-31evidence 0001354488-12-001441
FY 2010$2.1M2010-01-01 – 2010-12-31evidence 0001354488-12-001441
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

BioLife Solutions, Inc. — all facts · Net Income · Operating Income